UCA1 and prostate carcinoma: 6 reported that UCA1 promotes the progression of oral squamous cell carcinoma by activating the WNT/β‐catenin signaling pathway. Xiao et al. 7 demonstrated that UCA1 promotes epithelial‐mesenchymal transition (EMT) of breast cancer cells by enhancing the Wnt/beta‐catenin signaling pathway. UCA1 promotes the progression and regulates proliferation through the KLF4‐KRT6/13 signaling pathway in prostate cancer 8. UCA1 has been shown to be a novel diagnostic and predictive biomarker in plasma for early GC 9. TGFβ1 induces the upregulation of UCA1, which promotes invasion and migration in GC 10.